loading

Regeneron Pharmaceuticals Inc (REGN) 最新ニュース

pulisher
10:38 AM

Is Regeneron at a Turning Point After 43% Drop and FDA Eye Drug Approval News? - simplywall.st

10:38 AM
pulisher
06:52 AM

Analysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Sysmex (SSMXF) - The Globe and Mail

06:52 AM
pulisher
05:27 AM

Can you recover from losses in Regeneron Pharmaceuticals Inc.July 2025 Macro Moves & High Conviction Buy Zone Alerts - newser.com

05:27 AM
pulisher
05:19 AM

Can Regeneron Pharmaceuticals Inc. (RGO) stock deliver consistent EPS growthPortfolio Risk Summary & Verified Entry Point Signals - newser.com

05:19 AM
pulisher
05:09 AM

Leo Wealth LLC Boosts Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

05:09 AM
pulisher
04:56 AM

Will Regeneron Pharmaceuticals Inc. continue its uptrendJuly 2025 News Drivers & Proven Capital Preservation Tips - newser.com

04:56 AM
pulisher
04:55 AM

Regeneron Pharmaceuticals Inc. stock daily chart insights2025 Institutional Moves & Verified Entry Point Signals - newser.com

04:55 AM
pulisher
Oct 09, 2025

Forecasting Regeneron Pharmaceuticals Inc. price range with options dataEntry Point & Daily Oversold Bounce Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How Is Regeneron’s Stock Performance Compared to Other Pharma Stocks? - MSN

Oct 09, 2025
pulisher
Oct 09, 2025

Libtayo’s CSCC Label Expansion Broadens Practitioner Base - insights.citeline.com

Oct 09, 2025
pulisher
Oct 09, 2025

Regeneron's Libtayo Gains FDA Approval To Reduce Recurrence Risk In Skin Cancer Patients - Benzinga

Oct 09, 2025
pulisher
Oct 09, 2025

Retail Buzz Builds Around Regeneron After FDA Clears Libtayo For High-Risk Skin Cancer; Traders Eye ‘Buying Opportunity’ - Stocktwits

Oct 09, 2025
pulisher
Oct 09, 2025

Regeneron, needing a turnaround, gains new use for cancer drug - BioPharma Dive

Oct 09, 2025
pulisher
Oct 09, 2025

Regeneron Gets FDA Nod for Label Expansion of Oncology Drug Libtayo - The Globe and Mail

Oct 09, 2025
pulisher
Oct 09, 2025

New FDA approval for Libtayo - The Pharma Letter

Oct 09, 2025
pulisher
Oct 09, 2025

8,976 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Bar Harbor Wealth Management - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

FDA approves Regeneron’s Libtayo for high-risk CSCC post-surgery - Yahoo

Oct 09, 2025
pulisher
Oct 09, 2025

Bispecific Antibodies MarketGlobal Forecast 2025-2032, Profiles of Key PlayersF. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab - GlobeNewswire

Oct 09, 2025
pulisher
Oct 09, 2025

Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by QRG Capital Management Inc. - MarketBeat

Oct 09, 2025
pulisher
Oct 08, 2025

Regeneron Pharmaceuticals (REGN) Stock: Dips Despite FDA’s Breakthrough Approval for Libtayo in High-Risk CSCC - parameter.io

Oct 08, 2025
pulisher
Oct 08, 2025

US FDA expands use of Regeneron’s Libtayo as add-on treatment for skin cancer - 104.1 WIKY

Oct 08, 2025
pulisher
Oct 08, 2025

Libtayo approved in the U.S. for adjuvant treatment of cutaneous squamous cell carcinoma - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

US FDA expands use of Regeneron's Libtayo as add-on treatment for skin cancer - Reuters

Oct 08, 2025
pulisher
Oct 08, 2025

Regeneron (REGN) Gains FDA Approval for Cancer Therapy Libtayo - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

FDA Approves Regeneron's Libtayo for High-Risk Skin Cancer Treat - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

FDA Approves Regeneron's (REGN) Libtayo for High-Risk Skin Cance - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Regeneron Pharmaceuticals Announces FDA Approval of Libtayo® as Adjuvant Treatment for High-Risk Cutaneous Squamous Cell Carcinoma - Quiver Quantitative

Oct 08, 2025
pulisher
Oct 08, 2025

Regeneron stock rises after FDA approves Libtayo for high-risk skin cancer - Investing.com

Oct 08, 2025
pulisher
Oct 08, 2025

68% Risk Reduction: Regeneron's Libtayo Approved as First Adjuvant Immunotherapy for CSCC - Stock Titan

Oct 08, 2025
pulisher
Oct 08, 2025

Regeneron Pharma stock price target raised by RBC to $704 on Dupixent growth By Investing.com - Investing.com Nigeria

Oct 08, 2025
pulisher
Oct 08, 2025

Regeneron Pharma stock price target raised by RBC to $704 on Dupixent growth - Investing.com Nigeria

Oct 08, 2025
pulisher
Oct 08, 2025

RBC Raises Price Target on Regeneron Pharmaceuticals to $704 From $695, Keeps Sector Perform Rating - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Dohj LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

KLP Kapitalforvaltning AS Cuts Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by Valeo Financial Advisors LLC - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

Regeneron Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo

Oct 07, 2025
pulisher
Oct 07, 2025

Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Ameliora Wealth Management Ltd. - MarketBeat

Oct 07, 2025
pulisher
Oct 07, 2025

Regeneron (REGN): Reevaluating Valuation Following Breakthrough Trial Results and Evkeeza’s FDA Pediatric Approval - Yahoo Finance

Oct 07, 2025
pulisher
Oct 07, 2025

Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Slow Capital Inc. - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

Regeneron Pharmaceuticals to Acquire 23andMe for $256M - MSN

Oct 06, 2025
pulisher
Oct 06, 2025

Galderma Punches Above Its Weight Against Dermatology Goliaths - insights.citeline.com

Oct 06, 2025
pulisher
Oct 06, 2025

Regeneron Pharmaceuticals (REGN): Valuation in Focus Following Breakthrough Pipeline Results and Expanded Drug Approvals - simplywall.st

Oct 06, 2025
pulisher
Oct 06, 2025

Strategies to average down on Regeneron Pharmaceuticals Inc.2025 Top Gainers & Smart Investment Allocation Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Regeneron (REGN) Projects $83 Million R&D Charge in Q3 2025 - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

Regeneron expects $83 million IPR&D charge in third quarter 2025 results - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Top chart patterns to watch in Regeneron Pharmaceuticals Inc.Earnings Miss & Advanced Technical Signal Analysis - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can trapped investors hope for a rebound in Regeneron Pharmaceuticals Inc.Earnings Summary Report & Weekly High Potential Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Regeneron Pharmaceuticals Inc. stock resilient to inflationQuarterly Market Review & Verified Technical Trade Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

111 Capital Makes New $517,000 Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

J. Safra Sarasin Holding AG Sells 438 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Janney Montgomery Scott LLC Has $6.61 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Published on: 2025-10-06 01:04:19 - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Marietta Wealth Management LLC Has $6.01 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Oct 05, 2025
pulisher
Oct 05, 2025

Why pension funds invest in Regeneron Pharmaceuticals Inc. (RGO) stock2025 Support & Resistance & Daily Risk Controlled Trade Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Applying Elliott Wave Theory to Regeneron Pharmaceuticals Inc.Weekly Stock Recap & Accurate Buy Signal Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Why millennials buy Regeneron Pharmaceuticals Inc. (RGO) stockRisk Management & Expert Approved Momentum Trade Ideas - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Why Regeneron (REGN) Is Up 6.4% After FDA Expansion and Positive Late-Stage Trial Results - simplywall.st

Oct 04, 2025
pulisher
Oct 04, 2025

Mirae Asset Global Investments Co. Ltd. Grows Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Robeco Institutional Asset Management B.V. Trims Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Truist Financial Corp Decreases Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

Regeneron Pharmaceuticals catalysts could drive stock higher: analysts - Proactive financial news

Oct 03, 2025
$456.37
price down icon 0.04%
$799.64
price down icon 0.65%
biotechnology ONC
$320.84
price down icon 4.25%
$163.37
price down icon 0.64%
$102.17
price down icon 2.21%
大文字化:     |  ボリューム (24 時間):